Probiotic for early Alzheimer's: safety and memory benefits
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a new probiotic (Lactococcus lactis CKDB001) to see if it can slow memory loss in people with early Alzheimer's. It’s a 12-week study that requires a positive amyloid PET scan and allows mild to moderate symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 85 years old.
- You have been diagnosed with early-stage Alzheimer's disease or mild cognitive impairment.
- A PET scan has shown amyloid buildup in your brain (a key sign of Alzheimer's).
- You do not have other serious brain conditions, uncontrolled health issues, or recent major changes to Alzheimer's medications.
- You are not taking medications that affect the gut bacteria, like certain antibiotics, within the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called BEY2153 for people with early Alzheimer's disease. It aims to see if the drug is safe and can help slow memory decline.
This study tests whether daily probiotics (beneficial bacteria) can help people with mild Alzheimer's disease. It's an early-phase trial to see if probiotics are safe and might improve thinking and memory.
This study tests whether a probiotic (a supplement with helpful bacteria) can help slow down memory and thinking problems in people with mild cognitive impairment (MCI). It is for adults aged 60–85 who have noticed their memory getting worse over time but can still handle daily activities.
This study looks at how a probiotic supplement affects the gut and thinking in older adults, including those with mild cognitive impairment or Alzheimer's. It may help explain if improving gut health can support brain health.
This study tests whether taking a specific probiotic (a beneficial bacteria) can help improve memory and thinking in people with mild cognitive impairment who show signs of amyloid in the brain. If you qualify, you'll be randomly assigned to receive either the probiotic or a placebo (a dummy pill) to see if it helps.
This study tests whether a daily probiotic milk drink can improve gut and brain health in older adults with Alzheimer's or related dementias, and their caregivers. Participants will drink the probiotic or a placebo for a period, and the researchers will look at changes in health.
Hear when a new Early Alzheimer's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.